Delivery Order SPE2DB22D2007-SPE2DB24FJ2DW
Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The $4,104.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,966.93, is for the delivery of 4563374242 - Oxcarbazepine 300 mg/5 ml Suspension 250 ml. The contract is a Delivery Order with a Firm Fixed Price type and has an ultimate completion date of January 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This federal contract award is for the delivery of Oxcarbazepine 300 mg/5 ml Suspension, 250 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,161.36, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 26, 2024. It is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract, valued at $3,268.33, is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of October 30, 2023 and was awarded on October 27, 2022. This contract is not...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,171.85, is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 29, 2023. This award is not associated with a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,135.08 firm fixed price delivery order is for the supply of 4564340652 - Oxcarbazepine 300 mg/5 ml Suspension in 250 ml bottles. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Oxcarbazepine 600 mg tablets, a neurological medication, with a ceiling value of $1,792.41 and a performance period through June 2025. The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.65 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication commonly used in neurological treatment regimens. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in...
- This federal contract award, identified as SPE2DB20D1100|SPE2DB25FB7U5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,552.55 fixed-price delivery order is for the supply of 4567943087 - OXCARBAZEPINE ER 600 MG TABLET 100S, with a completion date of April 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.46 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Oxcarbazepine 150 mg, an anticonvulsant medication commonly used to treat neurological conditions. This firm fixed-price delivery order, issued on September 22, 2025, with completion expected by September 23, 2025, represents a non-competitive set-aside purchase that leverages AmerisourceBergen's existing contract vehicle with DLA. The contractor will...